Hikma Still Sees Value In Generic Advair Despite Teva’s US Approval

CEO Predicts Launch From Teva Later This Year; Also Comments On Vascepa Competition

 
• By Dave Wallace
Three Hands Take Slices Of Pie
Three firms could soon be competing for a slice of the US generic Advair market • Source: YesPhotographers / Alamy Stock Photo

More from Generics

More from Products